Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient

International Archives of Allergy and Immunology

Volumn 149, Issue 2, 2009, Pages 173-177

  Calligaris, Lorenzo ^a   Stocco, Gabriele ^a,c   De Iudicibus, Sara ^a,c   Marino, Sara ^a,c   Decorti, Giuliana ^c   Barbi, Egidio ^a   Carrozzi, Marco ^a   Marchetti, Federico ^a   Bartoli, Fiora ^b   Ventura, Alessandro ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b Department of Reproductive and Developmental Sciences ^*  (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Carbamazepine; Epoxide hydrolases; Herpesviridae; Human leukocyte antigen; Hypersensitivity; Lymphocyte activation; Pharmacogenetics

Indexed keywords

AMOXICILLIN; CARBAMAZEPINE; EPOXIDE HYDROLASE; HLA ANTIGEN; IBUPROFEN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PARACETAMOL; VALPROIC ACID; VIRUS ANTIBODY; VIRUS DNA;

ANTIBODY TITER; ARTICLE; CASE REPORT; CAUCASIAN; CERVICAL LYMPHADENOPATHY; CHILD; DISEASE ASSOCIATION; DRESS SYNDROME; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EEG ABNORMALITY; ERYTHEMA; FACE EDEMA; FEMALE; FEVER; GENE FREQUENCY; GENE INTERACTION; GENERALIZED EPILEPSY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HERPES SIMPLEX; HOMOZYGOSITY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SCHOOL CHILD; SIMPLE PARTIAL SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; VIRUS REACTIVATION;

ANTICONVULSANTS; CARBAMAZEPINE; CELLS, CULTURED; CHILD; DRUG HYPERSENSITIVITY; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HLA-A ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; POLYMORPHISM, SINGLE NUCLEOTIDE; SYNDROME; VIRUS ACTIVATION;

EID: 58149142550     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189202     Document Type: Article

References (25)

1. Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmo-hamed M, Park BK: Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol 2003; 63:732-741.
2. Gerber BO, Pichler WJ: Cellular mechanisms of T cell mediated drug hypersensitiv-ity. Curr Opin Immunol 2004; 16:732-737.
3. Pichler WJ, Tilch J: The lymphocyte transformation test in the diagnosis of drug hy-persensitivity. Allergy 2004; 59:809-820.
4. Svensson CK, Cowen EW, Gaspari AA: Cutaneous drug reactions. Pharmacol Rev 2001; 53:357-379.
5. Levy M: Role of viral infections in the induction of adverse drug reactions. Drug Saf 1997; 16:1-8.
6. Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT: Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428:486.
7. Lonjou C, Thomas L, Borot N, Ledger N, de Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, Mockenhaupt M, Roujeau JC: A marker for Stevens-Johnson syndrome: ethnicity matters. Pharmacogenomics J 2006; 6:265-268.
8. Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M: A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 2008; 18: 99-107.
9. Green VJ, Pirmohamed M, Kitteringham NR, Gaedigk A, Grant DM, Boxer M, Burchell B, Park BK: Genetic analysis of microsomal epoxide hydrolase in patients with carbam-azepine hypersensitivity. Biochem Pharmacol 1995; 50:1353-1359.
10. Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jagel-Guedes E, Ru-gina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thor-born D, Benbow A: HLA-B *5701 screening for hypersensitivity to abacavir. N Engl J Med 2008; 358:568-579.
11. The International HapMap Consortium: The international HapMap project. Nature 2003; 426: 789-796.
12. Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Chen WH, Shih HY, Fang WH, Wei CY, Lou YH, Huang YL, Lin JJ, Chen YT: Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 2006; 16:297-306.
13. Smith CA, Harrison DJ: Association between polymorphism in gene for microsom-al epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350: 630-633.
14. Nyfeler B, Pichler WJ: The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997; 27: 175-181.
15. Oskay T, Karademir A, Erturk OI: Association of anticonvulsant hypersensitivity syndrome with herpesvirus 6, 7. Epilepsy Res 2006; 70: 27-40.
16. Mitani N, Aihara M, Yamakawa Y, Yamada M, Itoh N, Mizuki N, Ikezawa Z: Drug-induced hypersensitivity syndrome due to cy-anamide associated with multiple reactivation of human herpesviruses. J Med Virol 2005; 75:430-434.
17. Yagami A, Yoshikawa T, Asano Y, Koie S, Shiohara T, Matsunaga K: Drug-induced hy-persensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7. Dermatology 2006; 213: 341-344.
18. Lusso P: HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J Clin Virol 2006; 37(suppl 1):S4-S10.
19. Kano Y, Inaoka M, Shiohara T: Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004; 140:183-188.
20. Patsalos PN, Perucca E: Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2003; 2: 347-356.
21. Vittorio CC, Muglia JJ: Anticonvulsant hy-persensitivity syndrome. Arch Intern Med 1995; 155: 2285-2290.
22. Klotz U: The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharma-cokinetic and therapeutic implications. Clin Pharmacokinet 2007; 46: 271-279.
23. Alfirevic A, Mills T, Harrington P, Pinel T, Sherwood J, Jawaid A, Smith JC, March RE, Barratt BJ, Chadwick DW, Kevin Park B, Pir-mohamed M: Serious carbamazepine-in-duced hypersensitivity reactions associated with the hsp70 gene cluster. Pharmacogenet Genomics 2006; 16:287-296.
24. Gourraud PA, Feolo M, Hoffman D, Helmberg W, Cambon-Thomsen A: The DBMHC microsatellite portal: a public resource for the storage and display of MHC microsatellite information. Tissue Antigens 2006; 67: 395-401.
25. Ingelman-Sundberg M: Pharmacogenomic biomarkers for prediction of severe adverse drug react ions. N Engl J Med 2008; 358: 637-639.